Portosystemic shunt, congenital

Very rare: prevalence estimated at 1/30,000 births. It consists in a direct communication between the portal network and the inferior caval vein or one of its afferents, probably due to an incomplete involution of the vitelline veins

.

Different types:

- intrahepatic shunts: abnormal connections between a branch of the portal vein and the hepatic veins or the IVC, including the  ductus venosus of Arantius

- extrahepatic shunts: communication between the portal vein and the IVC:

The age of diagnosis is highly variable: from the neonatal period to early childhood.

The signs and possible symptoms are:

-        a hypergalactosemia (neonatal screening)

-        hyperammonemia with signs ranging from hepatic encephalopathy to behavioral problems

-        neonatal cholestasis

-        hepato-pulmonary syndrome

-        porto-pulmonary hypertension

-        a liver tumor: adenomas or nodular hyperplasia localized or regenerative, which usually regress when the shunt is interrupted

-        the diagnosis is sometimes made during an antenatal echography.

Other cardiovascular malformations are sometimes associated: ASD, coarctation of the aorta, malformation of the IVC, etc.


The treatment is controversial:

-        most of the intrahepatic shunts close spontaneously and without any sequelae before 2 years of age.

-        intrahepatic or extrahepatic shunts type 1: liver transplantation

-        in case of signs of encephalopathy or hepato-pulmonary syndrome, one can perform a ligature or embolization of the extrahepatic shunt (type 2) or embolization of intrahepatic shunts. However, these treatments must be made with caution because they can cause acute portal hypertension in case of hypoplasia of the intrahepatic portal network. It is therefore recommended to perform an occlusion test (balloon or clamp) and measure portal pressure before permanently closing the shunt.


Anesthetic implications:

check liver function and the absence of hepato-pulmonary syndrome or pulmonary arterial hypertension; absence of first-pass effect for the medicaments administered orally or IV.


References : 

-     Kim MJ, Ko JS, Seo JK, Yang HR, Chang JY, Kim GB, Cheon J-E, Kim WS. 
Clinical features of congenital portosystemic shunt in children. 
Eur J Pediatr 2012 ; 171 : 395-400.

-        Passalacqua M, Lie KT, Yarmohammadi H. 
Congenital extrahepatic portosystemic shunt (Abernethy malformation) treated endovascularly with vascular plug shunt closure. 
Pediatr Surg Int 2012; 28: 79-83.

-         Law YM, Mack CL, Sokol RJ, Rice M, Parsley L, Ivy D. 
Cardioplumonary manifestations of portovenous shunts from congenital absence of the portal vein: pulmonary hypertension and pulmonary vascular dilatation
Pediatr Transplantation 2011; 15: E162-8.

-         Hubert G, Giniès J-L, Dabadie A, Tourtelier Y, Willot S, Patiente D, Lefrançois T, Caldari D. 
Shunts porto-systémiques congénitaux : expérience du Grand-Ouest sur cinq ans. 
Arch Pédiatr 2014 ; 21 : 1187-94.

-        Takechi K, Kitamura S, Fujii S, Soutani M, Yorozuya T, Nagaro T.
Delayed emergence from anaesthesia in a patient with agenesia of the ductus venosus.
Anaesthesia Cases 2014; 2: 80-3

-        Uike K, Nagata H, Hirata Y, Yamamura K, Terashi E et al.
Effective shunt closure for pulmonary hypertension and liver dysfunction in congenital portosystemic venous shunt.
Pediatr Pulmonol 2018; 53: 505-11.

-        Cytter-Kuint R, Slae M, Kvyat K, Shteyer E.
Characterization and natural history of congenital intrahepatic portosystemic shunts.
Eur J Pediatr 2021; 180:1733-7.


Updated: May 2021